Orbimed Advisors LLC

Orbimed Advisors LLC reported 124 holdings worth US$5.5B as of Sep 30, 2026 (Form 13F)

As of Sep 30, 2026 · Filed Nov 16, 2026

Orbimed Advisors LLC reported 124 holdings worth US$5.5B as of Sep 30, 2026. Largest: Edgewise Therapeutics, Inc., ADARx Pharmaceuticals, Inc. and Enliven Therapeutics, Inc. Filed Nov 16, 2026 (Form 13F).

Holdings
124
Value as reported
US$5.5B

The filing in full

CompanySharesValue as reported% of portfolio
Edgewise Therapeutics, Inc.15.5MUS$630M11.5%
ADARx Pharmaceuticals, Inc.24.2MUS$483M8.8%
Enliven Therapeutics, Inc.6.78MUS$311M5.6%
Eli Lilly and Company258KUS$298M5.4%
Braveheart Bio, Inc.12.2MUS$246M4.5%
Sinovac Biotech, Ltd.2.72MUS$196M3.6%
MBX Biosciences, Inc.3.07MUS$180M3.3%
Merck & Company, Inc.946KUS$137M2.5%
Guardant Health, Inc.584KUS$104M1.9%
ArriVent BioPharma, Inc.3.03MUS$91.7M1.7%
Corvus Pharmaceuticals, Inc.7.17MUS$82.5M1.5%
Natera, Inc.200KUS$82.5M1.5%
Arcutis Biotherapeutics, Inc.3.12MUS$82.5M1.5%
Thermo Fisher Scientific Inc120KUS$81.3M1.5%
UnitedHealth Group Incorporated219KUS$80.4M1.5%
Electra Therapeutics, Inc.6.89MUS$77.5M1.4%
argenx SE75,180US$72.1M1.3%
Edwards Lifesciences Corporation835KUS$72.1M1.3%
Travere Therapeutics, Inc.1.2MUS$70.7M1.3%
Tango Therapeutics, Inc.2.78MUS$69.3M1.3%
AbbVie Inc.260KUS$67.9M1.2%
Caris Life Sciences, Inc.2.19MUS$67.2M1.2%
Odyssey Therapeutics, Inc.3MUS$66.7M1.2%
Cogent Biosciences, Inc.2MUS$64.2M1.2%
CareDx, Inc.935KUS$60.8M1.1%
Praxis Precision Medicines, Inc.200KUS$58.4M1.1%
Abbott Laboratories579KUS$57.2M1.0%
Prelude Therapeutics Incorporated13.7MUS$53.7M0.98%
BlossomHill Therapeutics, Inc.2.71MUS$50.6M0.92%
Humana Inc.128KUS$48.8M0.89%
Shattuck Labs, Inc.6.31MUS$43M0.78%
Structure Therapeutics, Inc.1.33MUS$41.6M0.76%
Intuitive Surgical, Inc.96,800US$39.4M0.72%
Rhythm Pharmaceuticals, Inc.408KUS$38.8M0.71%
Mineralys Therapeutics, Inc.1.45MUS$36.6M0.66%
ARS Pharmaceuticals, Inc.8.29MUS$35.7M0.65%
Q32 Bio Inc.4.13MUS$34.1M0.62%
Krystal Biotech, Inc.97,700US$32.5M0.59%
Palvella Therapeutics, Inc.230KUS$31.7M0.58%
Axsome Therapeutics, Inc.171KUS$31.5M0.57%
Upstream Bio, Inc.5.69MUS$30M0.55%
West Pharmaceutical Services, Inc.80,180US$29.7M0.54%
Latigo Biotherapeutics, Inc.1.68MUS$28M0.51%
Celcuity Inc.315KUS$25M0.45%
Scribe Therapeutics Inc.1.35MUS$24.8M0.45%
DexCom, Inc.278KUS$24M0.44%
Nektar Therapeutics385KUS$23.3M0.42%
Vogenx Inc969KUS$22.1M0.40%
ORIC Pharmaceuticals, Inc.1.56MUS$21M0.38%
Aura Biosciences, Inc.3.33MUS$20.9M0.38%
Savara, Inc.3.96MUS$20.4M0.37%
Apnimed, Inc.925KUS$20.3M0.37%
Pyxis Oncology, Inc.8.36MUS$19.5M0.35%
Achieve Life Sciences, Inc.2.34MUS$19M0.34%
Abivax SA185KUS$18.3M0.33%
Biogen Inc.79,400US$17.9M0.33%
Waters Corporation40,300US$17.7M0.32%
Definium Therapeutics, Inc.444KUS$16.9M0.31%
Celldex Therapeutics, Inc.505KUS$16.4M0.30%
Compass Therapeutics, Inc.15.2MUS$15.8M0.29%
CVS Health Corporation183KUS$15.6M0.28%
NeuroPace, Inc.1.06MUS$14.5M0.26%
Whitehawk Therapeutics, Inc.3.85MUS$14.5M0.26%
Revolution Medicines, Inc.70,500US$14.5M0.26%
Trevi Therapeutics, Inc.965KUS$13.8M0.25%
Vertex Pharmaceuticals Incorporated26,200US$13.7M0.25%
Sionna Therapeutics, Inc.2.47MUS$13M0.24%
Arrowhead Pharmaceuticals, Inc.194KUS$12.7M0.23%
BioCryst Pharmaceuticals, Inc.1.51MUS$12.5M0.23%
Sutro Biopharma, Inc.744KUS$12M0.22%
Erasca, Inc.806KUS$11.8M0.21%
Spruce Biosciences, Inc.243KUS$11.8M0.21%
Corbus Pharmaceuticals Holdings, Inc.1.67MUS$11.4M0.21%
Lexeo Therapeutics, Inc.3.2MUS$10.8M0.20%
Taysha Gene Therapies, Inc.2MUS$9.74M0.18%
Janux Therapeutics, Inc.525KUS$9.07M0.16%
Keros Therapeutics, Inc.759KUS$8.65M0.16%
Relmada Therapeutics, Inc.1.67MUS$6.3M0.11%
Adicet Bio, Inc.845KUS$6.03M0.11%
Xilio Therapeutics, Inc.592KUS$5.36M0.10%
BioAge Labs, Inc.712KUS$5.05M0.09%
Immunic, Inc.476KUS$4.42M0.08%
Spyre Therapeutics, Inc.47,326US$4.21M0.08%
ImageneBio, Inc.909KUS$4.16M0.08%
Danaher Corporation18,600US$4.12M0.07%
Alumis Inc.548KUS$4.05M0.07%
Bright Minds Biosciences Inc.81,000US$4.04M0.07%
Madrigal Pharmaceuticals, Inc.8,000US$4.03M0.07%
Artivion, Inc.175KUS$3.99M0.07%
Tectonic Therapeutic, Inc.166KUS$3.87M0.07%
ALX Oncology Holdings Inc.2.74MUS$3.81M0.07%
Dianthus Therapeutics, Inc.42,300US$3.72M0.07%
Zentalis Pharmaceuticals, Inc.1.32MUS$3.64M0.07%
BioMarin Pharmaceutical Inc.54,300US$3.26M0.06%
PTC Therapeutics, Inc.49,100US$3.18M0.06%
Bruker Corporation48,400US$3.13M0.06%
Tarsus Pharmaceuticals, Inc.34,600US$2.72M0.05%
EyePoint, Inc.740KUS$2.42M0.04%
Belite Bio, Inc.13,300US$2.26M0.04%
InspireMD Inc.3.13MUS$2.09M0.04%

Every holding of Orbimed Advisors LLC

Source

Download original · View original at SEC

Related